EDIT
Price
$1.58
Change
+$0.04 (+2.60%)
Updated
Apr 28 closing price
Capitalization
132.26M
One day until earnings call
RPTX
Price
$1.36
Change
+$0.11 (+8.80%)
Updated
Apr 28 closing price
Capitalization
57.81M
14 days until earnings call
Ad is loading...

EDIT vs RPTX

Header iconEDIT vs RPTX Comparison
Open Charts EDIT vs RPTXBanner chart's image
Editas Medicine
Price$1.58
Change+$0.04 (+2.60%)
Volume$1.93M
Capitalization132.26M
Repare Therapeutics
Price$1.36
Change+$0.11 (+8.80%)
Volume$276.02K
Capitalization57.81M
EDIT vs RPTX Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. RPTX commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a StrongBuy and RPTX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (EDIT: $1.58 vs. RPTX: $1.36)
Brand notoriety: EDIT and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 74% vs. RPTX: 82%
Market capitalization -- EDIT: $132.26M vs. RPTX: $57.81M
EDIT [@Biotechnology] is valued at $132.26M. RPTX’s [@Biotechnology] market capitalization is $57.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 5 bearish.
  • RPTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +18.80% price change this week, while RPTX (@Biotechnology) price change was +13.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.10%. For the same industry, the average monthly price growth was -2.09%, and the average quarterly price growth was -11.07%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

RPTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($132M) has a higher market cap than RPTX($57.8M). EDIT YTD gains are higher at: 24.409 vs. RPTX (3.817). RPTX has higher annual earnings (EBITDA): -90.22M vs. EDIT (-233.11M). EDIT has more cash in the bank: 270M vs. RPTX (153M). RPTX has less debt than EDIT: RPTX (1.93M) vs EDIT (35M). RPTX has higher revenues than EDIT: RPTX (53.5M) vs EDIT (32.3M).
EDITRPTXEDIT / RPTX
Capitalization132M57.8M228%
EBITDA-233.11M-90.22M258%
Gain YTD24.4093.817640%
P/E RatioN/AN/A-
Revenue32.3M53.5M60%
Total Cash270M153M176%
Total Debt35M1.93M1,811%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITRPTX
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 22 days ago
89%
Bearish Trend 20 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+2.60%
CRSP - EDIT
53%
Loosely correlated
-1.02%
PRME - EDIT
51%
Loosely correlated
-1.78%
NTLA - EDIT
48%
Loosely correlated
+2.05%
ABCL - EDIT
46%
Loosely correlated
+0.78%
RXRX - EDIT
45%
Loosely correlated
+1.92%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+8.80%
INO - RPTX
57%
Loosely correlated
+1.07%
BCYC - RPTX
47%
Loosely correlated
-0.24%
CADL - RPTX
38%
Loosely correlated
-0.20%
EDIT - RPTX
31%
Poorly correlated
+2.60%
PALI - RPTX
31%
Poorly correlated
+7.82%
More